Production (Stage)
HCA Healthcare, Inc.
HCA
$376.59
-$0.05-0.01%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 11.96% | 13.23% | -13.07% | -8.17% | -1.00% |
Total Depreciation and Amortization | 0.47% | 1.66% | 2.81% | 3.02% | 0.76% |
Total Amortization of Deferred Charges | 22.22% | 0.00% | 12.50% | -11.11% | 0.00% |
Total Other Non-Cash Items | 26.40% | 154.89% | 860.00% | -105.79% | 22.02% |
Change in Net Operating Assets | -299.76% | -137.41% | 500.00% | 46.79% | -134.51% |
Cash from Operations | -35.48% | -27.20% | 78.34% | -20.17% | -7.67% |
Capital Expenditure | 22.88% | -7.89% | 7.03% | -14.58% | 3.54% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -440.48% | 54.84% | -165.71% | 63.54% | 72.88% |
Divestitures | 906.25% | 1,500.00% | 0.00% | -99.68% | 3,000.00% |
Other Investing Activities | 171.43% | 49.28% | -305.88% | -1,800.00% | 101.06% |
Cash from Investing | 23.33% | 0.44% | -1.50% | -47.51% | 43.46% |
Total Debt Issued | -- | -100.00% | -- | -100.00% | 111,975.00% |
Total Debt Repaid | -5,985.94% | 93.10% | -243.28% | 116.40% | -2,268.13% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -47.41% | 5.29% | -31.31% | -15.85% | -29.67% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -9.09% | 2.37% | 1.17% | 7.57% | -15.63% |
Other Financing Activities | -56.84% | -1.30% | -14.36% | 47.94% | -150.32% |
Cash from Financing | 30.88% | -1,866.36% | 89.94% | 10.12% | -17.04% |
Foreign Exchange rate Adjustments | 160.00% | -225.00% | 300.00% | 200.00% | -116.67% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 8.59% | -146.43% | 554.08% | -229.80% | 693.18% |